Evelo Biosciences * website screenshot

Evelo Biosciences *

Evelo Biosciences was a Flagship Pioneering-founded, GV-backed microbiome biotechnology company in Cambridge, Massachusetts, developing orally delivered investigational medicines acting on the small intestinal axis. Following clinical failures of its lead candidates EDP1815 and EDP2939, the company announced dissolution in November 2023 and has been wound down. It is retained in the API Evangelist network as a dissolved life-sciences portfolio record: the evelobio.com domain now serves only a parked catch-all error page and the company publishes no developer portal, documentation, or API surface of any kind.

Evelo Biosciences * is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Microbiome, and Pharmaceuticals.

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyMicrobiomePharmaceuticalsDissolvedVenture Backed

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/evelo-biosciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Evelo Biosciences Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: evelo-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/evelo-biosciences.png
name: Evelo Biosciences *
description: 'Evelo Biosciences was a Flagship Pioneering-founded, GV-backed microbiome biotechnology company in Cambridge,
  Massachusetts, developing orally delivered investigational medicines acting on the small intestinal axis. Following clinical
  failures of its lead candidates EDP1815 and EDP2939, the company announced dissolution in November 2023 and has been wound
  down. It is retained in the API Evangelist network as a dissolved life-sciences portfolio record: the evelobio.com domain
  now serves only a parked catch-all error page and the company publishes no developer portal, documentation, or API surface
  of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/evelo-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
x-status: dissolved
x-status-detail: Evelo Biosciences (Flagship Pioneering microbiome biotech) announced dissolution in November 2023 after clinical
  failures of EDP1815 and EDP2939 and exhausting funding options. The company is wound down; evelobio.com now serves a parked
  error page with broken HTTPS and no developer/API surface. No real artifacts are available to enrich.
x-status-source: https://www.fiercebiotech.com/biotech/evelos-voyage-ends-flagship-founded-biotech-finds-dissolution-only-viable-option
x-enrichment-checked: '2026-07-20'
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Life Sciences
- Biotechnology
- Microbiome
- Pharmaceuticals
- Dissolved
- Venture Backed
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/evelo-biosciences-domain-security.yml
- type: Website
  url: http://evelobio.com
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1